Sara Sampietro/LinkedIn
Nov 26, 2025, 10:32
Sara Sampietro Introduces The New HemosIL Chromogenic Factor IX
Sara Sampietro, Product Manager – EEMEA at Werfen, shared on LinkedIn:
”Last week in Nyborg, Denmark, I had the privilege to discuss the role of the laboratory in the management of patients with Hemophilia and introduce our latest release: the NEW HemosIL Chromogenic Factor IX.
A big thanks to our partner ILS and to everyone who joined the conversation and contributed to driving progress in Hemostasis care.
Together, we can continue to make a difference!”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda